ALX Oncology Holdings Inc. (NASDAQ:ALXO), a biopharmaceutical company currently valued at $93.36 million, has announced the adoption of a new equity incentive plan, effective January 16, 2025. The ...
It also doesn't require much detective work to figure out that Galaxy AI will be a big part of Samsung's Galaxy S25 sales pitch. The phone maker introduced its collection of new A ...